The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company’s aptamers market report forecasts the aptamers market size to grow to $4.98 Billion by 2027, with a CAGR (compound annual growth rate) of more than 23%.

Learn More On The Aptamers Market Report 2023 – https://www.thebusinessresearchcompany.com/report/aptamers-global-market-report

Aptamers Market Size Forecast
The global aptamers market is expected to grow from $1.75 billion in 2022 to $2.16 billion in 2023 at a compound annual growth rate (CAGR) of 23.6%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The aptamers market is expected to grow to $4.98 billion in 2027 at a CAGR of 23.2%.

North America held the largest aptamers market share.

Key Aptamers Market Driver ­– Increase In The Prevalence Of Chronic Respiratory Diseases
For instance, according to data from the Centers for Disease Control and Prevention (CDC), a US-based public health agency, 8.4% of people over 18 and 5.8% of children had asthma in the US in 2020. Furthermore, in May 2021, according to a report shared by the Asthma and Allergy Foundation of America, a US-based non-profit organization, the number of Americans who have asthma will be over 25 million. Therefore, the rising prevalence of chronic respiratory diseases is driving the growth of the aptamers market.

Request for A Sample Of The Global Aptamers Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8156&type=smp

Key Aptamers Market Trend – Technological Innovations
Major companies operating in the market are introducing new technologies, such as artificial DNA aptamers, which are manufactured using adaptable and seamless technology to sustain their position in the market. For instance, in May 2021, NEC Corporation, a Japan-based multinational information technology and electronics corporation, developed artificial DNA aptamers that can bind to the novel coronavirus (SARS-CoV-2). With the help of adaptable and seamless technology, an aptamer can enter the body to target RBD, which is the key to infection, and trap the virus by identifying the three-dimensional structure of the receptor-binding domain (RBD), forming a solid bond with it.

Aptamers Market Segment
1) By Type: DNA Aptamers, XNA Aptamers, RNA Aptamers
2) By Technology: SELEX, X Aptamer, Maras Technique
3) By Application: Therapeutics Development, Research and Development, Diagnostic, Other Applications
4) By End User: Pharmaceutical and Biotechnology Companies, Academic and Government Research Institutes, Cathode-Ray Oscilloscope, Other End Users

Aptamers Market Major Players and Strategies
Major players in the aptamers market are Aptamer Group, SomaLogic Inc., Aptamer Sciences Inc., Aptagen LLC, NeoVentures Biotechnology Inc., Aptus Biotech, Base Pair Biotechnologies, AMSBIO, Vivonics Inc., TriLink Biotechnologies, Noxxon Pharma, AM Biotechnologies LLC, Raptamer Discovery Group, Kaneka Corporation, and Novaptech.

In May 2022, Epicore Biosystems, a US-based digital health and wearable solutions company, acquired Eccrine Systems and its advanced aptamer-based sweat sensing technology for an undisclosed amount. This acquisition adds further sensor technology to Epicore’s line of wearable microfluidic solutions. Eccrine Systems, a US-based wearable sensor provider, and provider of electrochemical aptamer-based technology to choose biomarkers to quantify a target of choice.

The Aptamers Global Market Report 2023 covers regional data on aptamers market size, aptamers market trends and drivers, opportunities, strategies, and aptamers market competitor analysis. The countries covered in the aptamers market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

Aptamers are short synthetic single-stranded oligonucleotides that fold into defined architectures and bind to target antigens such as proteins, molecules, peptides, cells, and tissues. It is used for the molecular recognition of their respective targets.

View More Reports Related To The Aptamers Market –
Oligonucleotide Therapy Global Market Report 2023
Gene Therapy Global Market Report 2023
Nucleic Acid Based Gene Therapy Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on: